Table 1.
Patient Characteristics
| Variable | Value, n (%) (n=200) |
|---|---|
| Age at transplant, mean ± SD | 51.2 ± 12.58 |
| Sex, Male | 144 (72) |
| Disease category | |
| Group A (COPD) | 57 (28.5) |
| Group B (Pulmonary hypertension) | 7 (3.5) |
| Group C (Cystic fibrosis) | 26 (13.0) |
| Group D (Pulmonary fibrosis) | 110 (55.0) |
| Medical condition at transplant | |
| ICU | 21 (10.5) |
| Hospitalized | 5 (2.5) |
| Outpatient | 174 (87.0) |
| Zubrod score | |
| 1 | 82 (42.7) |
| 2 | 73 (38.0) |
| 3 | 20 (10.4) |
| 4 | 17 (8.9) |
| Pre-transplant ECMO | 9 (4.5) |
| Pre-transplant Ventilator | 15 (7.5) |
| BMI, mean ± SD | 26.1 ± 5.03 |
| Serum creatinine, mean ± SD | 0.82 ±0.22 |
| Bilirubin, mean ± SD | 0.71 ± 1.16 |
| Donor CMV+/Recipient CMV− | 60 (30) |
| %Predicted FVC, mean ± SD | 47.7 ± 19.0 |
| LAS at transplant, median (IQR) | 40.98 (IQR 36.1 –52.2) |
| Donor age, mean | 35.1 |
| Transplant organ | |
| Single | 62 (31.0) |
| Bilateral | 138 (69.0) |
| Cardiopulmonary bypass | 85 (42.5) |
| Total ischemic time (minutes), mean | 355.5 |
| Initial ventilator support >48 hours | 46 (23) |
| Postoperative ECMO | 10 (5) |
| Pneumonia | 31 (15.5) |
| Tracheostomy | 32 (16.0) |
| Post-transplant dialysis | 14 (7.0) |
| Feeding tube | 33 (16.5) |
| Induction with basiliximab | 56 (28) |
| Grade 3 primary graft dysfunction | 22 (11) |
| Acute rejection | 117 (58.5) |
| Length of stay (days), median | 17.0 |
| Acute inpatient rehabilitation | 15 (7.5) |
Abbreviations: BMI, body mass index; CMV, cytomegalovirus; COPD, chronic obstructive pulmonary Disease; ECMO, extracorporeal membrane oxygenation; IQR, interquartile range; LAS, lung allocation score; SD, standard deviation